Weight Loss  >>  Symlin (pramlintide)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Symlin (pramlintide) / AstraZeneca
NCT00112021: A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects

Completed
2b
400
US
pramlintide acetate, Pramlintide acetate injection (Pramlintide (0.6 mg/mL)) is a clear, colorless, sterile solution for SC injection
AstraZeneca
Obesity
11/05
11/05
NCT00189514: A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects

Completed
2
210
US
pramlintide acetate, Symlin, placebo
AstraZeneca
Obesity
06/07
06/07

Download Options